BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22102)

  • 21. [Methods for the investigation of the role of cyclic AMP in the hypophysis and hypothalamus (author's transl)].
    Klenerová V; Hynie S
    Sb Lek; 1978 Feb; 80(2):34-43. PubMed ID: 204982
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 23. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 26. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS; Tallman JF; Nestler EJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the catalytic site of adenylate cyclase in the central nervous system by phenothiazine derivatives.
    Palmer GC; Manian AA
    Neuropharmacology; 1974 Jul; 13(7):651-64. PubMed ID: 4155055
    [No Abstract]   [Full Text] [Related]  

  • 30. [The metabolism of drugs. LXXXV. The metabolism of 1-p-chlorophenyl-2,3-dimethyl-4-dimethylaminobutan-2-ol hydrochloride (author's transl)].
    Tatsumi K; Nakano M; Kitamura S; Yoshimura H
    Yakugaku Zasshi; 1975 Jun; 95(6):690-7. PubMed ID: 1237564
    [No Abstract]   [Full Text] [Related]  

  • 31. Stand-alone cognitive behavioural therapy is not in clinical equipoise with antipsychotic treatment - Author's reply.
    Morrison AP; Law H; Shiers D; Yung AR; Haddad PM
    Lancet Psychiatry; 2018 Jul; 5(7):540-541. PubMed ID: 29941130
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
    Karobath ME
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulators of cyclic AMP systems.
    Hess SM; Chasin M; Free CA; Harris DN
    Adv Biochem Psychopharmacol; 1975; (14):153-67. PubMed ID: 242200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychotropic drugs and adenylate cyclase (author's transl)].
    Honda F
    Tanpakushitsu Kakusan Koso; 1977; 22(6):822-6. PubMed ID: 22102
    [No Abstract]   [Full Text] [Related]  

  • 36. How do antipsychotic drugs work?
    Iversen LL
    Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
    Weiss B; Levin RM
    Adv Cyclic Nucleotide Res; 1978; 9():285-303. PubMed ID: 27079
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.